Definium Therapeutics, Inc. (DFTX) Q2 2026 Earnings Call Prepared Remarks Transcript

SA Transcripts 161.6K Followers Follow Definium Therapeutics, Inc. ( DFTX ) Q2 2026 Earnings Call August 6, 2026 4:30 PM EDT Company Participants Robert Barrow - CEO & Director Daniel Karlin - Chief Medical Officer Matthew Wiley - Chief Commercial Officer Brandi Roberts - Chief Financial Officer Presentation Operator Good afternoon. I am Gita Jain, Head of Investor Relations, and I want to thank you for joining us today for Definium Therapeutics Second Quarter 2026 Financial Results and Recent Highlights Conference Call. [Operator Instructions] This webcast is live on the Investors section of Definium's webcast at definiumtx.com, and a replay will be available after the webcast. Leading the call today will be Rob Barrow, our Chief Executive Officer, who is joined by Dr. Dan Karlin, our Chief Medical Officer; Brandi Roberts, our Chief Financial Officer; and Matt Wiley, our Chief Commercial Officer. During today's call, we will be making certain forward-looking statements, including, without limitation, statements about the potential safety, efficacy and regulatory and clinical progress of our product candidates, our anticipated cash runway and our future expectations, plans, partnerships and prospects. These statements are subject to various risks such as changes in market conditions and difficulties associated with research and development and regulatory approval processes. These and other risk factors are described in the filings made with the SEC and applicable Canadian securities regulators, including our annual report on Form 10-K and Form 10-Q filed today. Forward-looking statements are based on the assumptions, opinions and estimates of management at the date the statements are made, including the nonoccurrence of the risks and uncertainties that are described in the filings made with the SEC and the applicable Canadian securities regulators or other significant events occurring outside of Definium's normal course of business. You are cautioned not to place undue reliance on these forward-looking statements, which are made as of today, August 6, 2026.